Ether

Ether

SCHEMBL41293

CCOCC.CCOOCC

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL9248674 0.85 ALDH1A1 (0.47) ALDH1A1TSHR
Ether SCHEMBL6 0.85
Ether SCHEMBL21406 0.85 ALDH1A1 (0.47) ALDH1A1TSHR
Ether SCHEMBL9248046 0.85 ALDH1A1 (0.47) ALDH1A1TSHR
SCHEMBL27065 0.85
Ether SCHEMBL8160191 0.85 ALDH1A1 (0.47) ALDH1A1TSHR
Ether SCHEMBL8731224 0.84 ALDH1A1 (0.35) ALDH1A1
Ether SCHEMBL3653511 0.80
Ether SCHEMBL1312666 0.80 ALDH1A1 (0.44) ALDH1A1TSHR
Ether SCHEMBL8391342 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12448559-B1 Puddle job with delayed setting of resin via a polymerization reaction with an activator HALLIBURTON ENERGY SERVICES, INC. (US) 2025-10-21 US claimed
WO-2022153314-A1 A PROCESS FOR BLASTING TAMAR ISRAELI ADVANCED QUARRYING CO. LTD (IL) 2022-07-21 WO claimed
US-20220181580-A1 PASSIVATION METHOD OXFORD PHOTOVOLTAICS LIMITED (GB) 2022-06-09 US claimed
EP-3935134-A1 PASSIVATION METHOD Oxford University Innovation Limited (GB) 2022-01-12 EP claimed
CN-113574137-A Passivation method 牛津大学创新有限公司 2021-10-29 CN claimed
US-10981302-B2 Peroxide cross-linking and high temperature melting THE GENERAL HOSPITAL CORPORATION (US) 2021-04-20 US claimed
US-20190255744-A1 PEROXIDE CROSS-LINKING AND HIGH TEMPERATURE MELTING THE GENERAL HOSPITAL CORPORATION (US) 2019-08-22 US claimed
US-10220547-B2 Peroxide cross-linking and high temperature melting THE GENERAL HOSPITAL CORPORATION (US) 2019-03-05 US claimed
US-10126543-B2 Water content of a fluid of an electrowetting element AMAZON TECHNOLOGIES, INC. (US) 2018-11-13 US claimed
EP-2583130-B1 AN ELECTROWETTING ELEMENT AND FLUID AMAZON EUROPE HOLDING TECH SCS (LU) 2018-08-29 EP claimed
US-20150232422-A1 POLYURETHANE (METH) ACRYLATES USING MODIFIED HYDROXYTHIOLS DYMAX OLIGOMERS AND COATINGS LLC (US) 2015-08-20 US claimed
US-9029489-B2 Polyurethane (meth) acrylates using modified hydroxythiols DYMAX OLIGOMERS AND COATINGS LLC (US) 2015-05-12 US claimed
EP-2833931-A2 PEROXIDE CROSS-LINKING OF POLYMERIC MATERIALS IN THE PRESENCE OF ANTIOXIDANTS The General Hospital Corporation (US) 2015-02-11 EP claimed
WO-2014033738-A2 PROCESS FOR PREPARATION OF A SOLID OLIGOMERIZATION CATALYST AND APPLICATIONS THEREOF BHARAT PETROLEUM CORPORATION LIMITED (IN) 2014-03-06 WO claimed
WO-2013151960-A2 PEROXIDE CROSS-LINKING OF POLYMERIC MATERIALS IN THE PRESENCE OF ANTIOXIDANTS THE GENERAL HOSPITAL CORPORATION (US) 2013-10-10 WO claimed
US-20130109764-A1 ELECTROWETTING ELEMENT AND FLUID SAMSUNG LCD NETHERLANDS R & D CENTER B.V. (NL) 2013-05-02 US claimed
EP-2583130-A1 AN ELECTROWETTING ELEMENT AND FLUID Samsung LCD Netherlands R&D Center B.V. (NL) 2013-04-24 EP claimed
WO-2012003019-A1 POLYURETHANE (METH) ACRYLATES USING MODIFIELD HYDROXYTHIOLS BOMAR SPECIALTIES COMPANY (US) 2012-01-05 WO claimed
US-20110319580-A1 POLYURETHANE (METH) ACRYLATES USING MODIFIED HYDROXYTHIOLS BANK OF AMERICA, N.A. 2011-12-29 US claimed
WO-2011157826-A1 AN ELECTROWETTING ELEMENT AND FLUID SAMSUNG LCD NETHERLANDS R & D CENTER B.V. (NL) 2011-12-22 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319580-A1 POLYURETHANE (METH) ACRYLATES USING MODIFIED HYDROXYTHIOLS ESD, MMAB, BHMT2 ALDH1A1 33/4885TSHR 4724/4885
US-20150232422-A1 POLYURETHANE (METH) ACRYLATES USING MODIFIED HYDROXYTHIOLS ESD, MMAB, BHMT2 ALDH1A1 33/4885TSHR 4724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.